Abby Bronson
YOU?
Author Swipe
View article: A Phase 1, Double‐Blind, Placebo‐Controlled Trial of Sevasemten (<scp>EDG</scp>‐5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy
A Phase 1, Double‐Blind, Placebo‐Controlled Trial of Sevasemten (<span>EDG</span>‐5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy Open
Introduction/Aims Sevasemten (EDG‐5506) is an orally administered, investigational small molecule that selectively modulates fast muscle fiber contraction by inhibiting fast myosin ATPase. This study assessed the safety, tolerability, and …
View article: Mobilizing the clinical trial ecosystem to drive adoption of master protocols
Mobilizing the clinical trial ecosystem to drive adoption of master protocols Open
Master protocol studies typically use an overarching protocol to answer several questions by guiding a variety of sub-studies. These sub-studies can incorporate multiple diseases, therapies, or both. Although this innovative approach offer…
View article: Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials
Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials Open
[This corrects the article DOI: 10.2196/23011.].
View article: Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials (Preprint)
Correction: Data Sharing Goals for Nonprofit Funders of Clinical Trials (Preprint) Open
UNSTRUCTURED REMOVE
View article: Data Sharing Goals for Nonprofit Funders of Clinical Trials
Data Sharing Goals for Nonprofit Funders of Clinical Trials Open
Sharing clinical trial data can provide value to research participants and communities by accelerating the development of new knowledge and therapies as investigators merge data sets to conduct new analyses, reproduce published findings to…
View article: Data Sharing Goals for Nonprofit Funders of Clinical Trials (Preprint)
Data Sharing Goals for Nonprofit Funders of Clinical Trials (Preprint) Open
UNSTRUCTURED Sharing clinical trial data can provide value to research participants and communities by accelerating the development of new knowledge and therapies as investigators merge data sets to conduct new analyses, reproduce publish…
View article: Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy
Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy Open
The Duchenne Regulatory Science Consortium (D-RSC) was established to develop tools to accelerate drug development for DMD. The resulting tools are anticipated to meet validity requirements outlined by qualification/endorsement pathways at…